PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DUOT vs. PATH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DUOT and PATH is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

DUOT vs. PATH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Duos Technologies Group, Inc. (DUOT) and UiPath Inc. (PATH). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2025February
168.09%
17.41%
DUOT
PATH

Key characteristics

Sharpe Ratio

DUOT:

0.74

PATH:

-0.83

Sortino Ratio

DUOT:

1.70

PATH:

-0.95

Omega Ratio

DUOT:

1.20

PATH:

0.85

Calmar Ratio

DUOT:

0.75

PATH:

-0.50

Martin Ratio

DUOT:

2.08

PATH:

-1.04

Ulcer Index

DUOT:

35.82%

PATH:

42.15%

Daily Std Dev

DUOT:

101.13%

PATH:

52.74%

Max Drawdown

DUOT:

-99.66%

PATH:

-87.61%

Current Drawdown

DUOT:

-98.75%

PATH:

-83.11%

Fundamentals

Market Cap

DUOT:

$62.34M

PATH:

$7.90B

EPS

DUOT:

-$1.42

PATH:

-$0.16

PEG Ratio

DUOT:

0.00

PATH:

0.87

Total Revenue (TTM)

DUOT:

$5.82M

PATH:

$1.01B

Gross Profit (TTM)

DUOT:

$799.17K

PATH:

$823.02M

EBITDA (TTM)

DUOT:

-$5.51M

PATH:

-$182.16M

Returns By Period

The year-to-date returns for both investments are quite close, with DUOT having a 12.54% return and PATH slightly higher at 13.14%.


DUOT

YTD

12.54%

1M

16.03%

6M

168.13%

1Y

77.11%

5Y*

2.03%

10Y*

N/A

PATH

YTD

13.14%

1M

10.45%

6M

17.39%

1Y

-39.63%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DUOT vs. PATH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DUOT
The Risk-Adjusted Performance Rank of DUOT is 7171
Overall Rank
The Sharpe Ratio Rank of DUOT is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of DUOT is 7474
Sortino Ratio Rank
The Omega Ratio Rank of DUOT is 7171
Omega Ratio Rank
The Calmar Ratio Rank of DUOT is 7373
Calmar Ratio Rank
The Martin Ratio Rank of DUOT is 6666
Martin Ratio Rank

PATH
The Risk-Adjusted Performance Rank of PATH is 1313
Overall Rank
The Sharpe Ratio Rank of PATH is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of PATH is 1111
Sortino Ratio Rank
The Omega Ratio Rank of PATH is 99
Omega Ratio Rank
The Calmar Ratio Rank of PATH is 1717
Calmar Ratio Rank
The Martin Ratio Rank of PATH is 2121
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DUOT vs. PATH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Duos Technologies Group, Inc. (DUOT) and UiPath Inc. (PATH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DUOT, currently valued at 0.74, compared to the broader market-2.000.002.000.74-0.83
The chart of Sortino ratio for DUOT, currently valued at 1.70, compared to the broader market-4.00-2.000.002.004.006.001.70-0.95
The chart of Omega ratio for DUOT, currently valued at 1.20, compared to the broader market0.501.001.502.001.200.85
The chart of Calmar ratio for DUOT, currently valued at 0.93, compared to the broader market0.002.004.006.000.93-0.50
The chart of Martin ratio for DUOT, currently valued at 2.08, compared to the broader market0.0010.0020.0030.002.08-1.04
DUOT
PATH

The current DUOT Sharpe Ratio is 0.74, which is higher than the PATH Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of DUOT and PATH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.74
-0.83
DUOT
PATH

Dividends

DUOT vs. PATH - Dividend Comparison

Neither DUOT nor PATH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DUOT vs. PATH - Drawdown Comparison

The maximum DUOT drawdown since its inception was -99.66%, which is greater than PATH's maximum drawdown of -87.61%. Use the drawdown chart below to compare losses from any high point for DUOT and PATH. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%SeptemberOctoberNovemberDecember2025February
-38.26%
-83.11%
DUOT
PATH

Volatility

DUOT vs. PATH - Volatility Comparison

Duos Technologies Group, Inc. (DUOT) has a higher volatility of 33.11% compared to UiPath Inc. (PATH) at 16.16%. This indicates that DUOT's price experiences larger fluctuations and is considered to be riskier than PATH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
33.11%
16.16%
DUOT
PATH

Financials

DUOT vs. PATH - Financials Comparison

This section allows you to compare key financial metrics between Duos Technologies Group, Inc. and UiPath Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab